Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Viviscal Maximum Strength tablets
130900000BCAAA0
|
Proprietary compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | 3 |
|
Acitretin 5mg/5ml oral suspension
1305020A0AAAEAE
|
Acitretin | Acitretin | Skin | 2 |
|
Avoca 75% silver nitrate applicators with thick handles
1307000Q0BBAGAC
|
Avoca | Silver nitrate | Skin | 2 |
|
Betamethasone valerate 0.1% cream 25% in Coal tar paste
1304000F0AAEQEQ
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 2 |
|
Betnovate-C ointment
1304000F0BBAMCD
|
Betnovate (Topical) | Betamethasone valerate | Skin | 2 |
|
BioBag larvae sterile
1311070S0BCABAA
|
Ster Larvae (Biobags) | Ster larvae | Skin | 2 |
|
Calamine and Glycerin cream
1303000D0BHAAA0
|
Calamine and Glycerin (Boots) | Calamine | Skin | 2 |
|
Calcipotriol 50micrograms/g cream
1305020D0AAABAB
|
Calcipotriol | Calcipotriol | Skin | 2 |
|
Cetaphil cleansing bar
1311030A0BGABA0
|
Cetaphil | Alkyl sulphate | Skin | 2 |
|
Chlorhexidine gluconate 0.02% solution
1311020L0AAAPAP
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 2 |
|
ClobaDerm 0.05% ointment (Auden McKenzie)
1304000G0BFABBA
|
ClobaDerm | Clobetasol propionate | Skin | 2 |
|
Clobet .05% oint 50%/Propylene glycol 48%/Salic acid 2% oint
1304000G0AADMDM
|
Clobetasol propionate | Clobetasol propionate | Skin | 2 |
|
Clobetasol 0.05% ointment 20% in White soft paraffin
1304000G0AACPCP
|
Clobetasol propionate | Clobetasol propionate | Skin | 2 |
|
Coal tar 15% in Yellow soft paraffin
1305020C0AAEEEE
|
Coal tar/tar (Topical) | Tars | Skin | 2 |
|
Coal tar 2% in Yellow soft paraffin
1305020C0AADYDY
|
Coal tar/tar (Topical) | Tars | Skin | 2 |
|
Coal tar solution 5% in Emulsifying ointment
1305020C0AAESES
|
Coal tar/tar (Topical) | Tars | Skin | 2 |
|
Coal tar solution 5% in White soft paraffin
1305020C0AAEIEI
|
Coal tar/tar (Topical) | Tars | Skin | 2 |
|
Coconut oil 50% in White soft paraffin
130201000AADHDH
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
|
Coconut oil 75% in Emulsifying ointment
1302010F0AAANAN
|
Emulsifying wax (Emollient) | Emulsifying wax | Skin | 2 |
|
Derma Care Hydrocortisone 1% cream
1304000V0CUAAAD
|
Derma Care Hydrocortisone | Hydrocortisone | Skin | 2 |
|
Dithranol 1% in Zinc and Salicylic acid paste
1305020F0AAEQEQ
|
Dithranol (Topical) | Dithranol | Skin | 2 |
|
Elena's Body lotion
130501000BBBGA0
|
Proprietary compound preparation BNF 1305010 | Other eczema preparations | Skin | 2 |
|
Fluocinolone acetonide 0.0025% cream
1304000N0AAAEAE
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 2 |
|
Fucidin H ointment
1304000X0BHACCG
|
Fucidin H | Hydrocortisone acetate | Skin | 2 |
|
Generic E45 cream
130201000AAALAL
|
Generic compound emollients | Other emollient preparations | Skin | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.